Take Solutions returns to profit in FY26
Take Solutions Limited returned to profitability in FY26 with a net profit of ₹271.91 lakh, reversing the previous year's loss of ₹6,973.56 lakh. The turnaround was driven by the divestment of Ecron Acunova Limited and the clearance of debt obligations. Consolidated revenue from operations reached ₹5,418.53 lakh, while total equity improved to ₹3,100.14 lakh. Auditors issued a qualified opinion regarding pending tax assets.

*this image is generated using AI for illustrative purposes only.
Take Solutions Limited returned to profitability in the financial year ended March 31, 2026, posting a net profit of ₹271.91 lakh compared to a net loss of ₹6,973.56 lakh in the previous year. The turnaround was driven by the divestment of its wholly owned subsidiary, Ecron Acunova Limited, in FY 2024-25, and the subsequent clearance of immediate statutory and debt obligations using the proceeds. The company reported revenue from operations of ₹661.75 lakh for the year, while total income reached ₹661.75 lakh. The Board of Directors approved the audited financial results at its meeting held on May 20, 2026.
Standalone Financial Performance
The company’s standalone financial results for the year ended March 31, 2026, show a significant recovery in its financial position. Total expenditure for the year was ₹374.82 lakh, resulting in a profit before exceptional items and tax of ₹286.93 lakh. The company reported earnings per share (EPS) of ₹0.18 for continuing operations for the year.
| Metric | Year Ended March 31, 2026 (₹ in Lakhs) | Year Ended March 31, 2025 (₹ in Lakhs) |
|---|---|---|
| Total Income | 661.75 | 1,387.48 |
| Total Expenditure | 374.82 | 1,012.94 |
| Net Profit / (Loss) | 271.91 | (6,973.56) |
| Earnings Per Share (Basic) | 0.18 | (5.40) |
Consolidated Results
On a consolidated basis, the group reported a net profit of ₹1,084.91 lakh for the year ended March 31, 2026, compared to a net profit of ₹3,746.71 lakh in the previous year. The previous year's profit was primarily driven by the gain on the divestment of Ecron Acunova Limited. Consolidated revenue from operations for the current year stood at ₹5,418.53 lakh. The group’s total equity improved to ₹3,100.14 lakh as at March 31, 2026, from ₹2,052.75 lakh as at March 31, 2025.
Audit Qualifications
The statutory auditors, A. Raghavendra Rao & Associates, expressed a qualified opinion on both the standalone and consolidated financial results. The qualification relates to income tax assets (net) amounting to ₹875.80 lakh in the standalone statements and ₹1,291.90 lakh in the consolidated statements. These assets pertain to various assessment years and are subject to disputes pending before various forums. The management has assessed these amounts as fully recoverable, and no impairment has been recognised. The auditors noted that the ultimate realisable value of these tax assets remains contingent upon the outcome of the proceedings. This qualification is repetitive, having been reported since the year ended March 31, 2023.
Going Concern and Future Outlook
The auditors highlighted that the company has undertaken meaningful steps towards business diversification following the divestment. The ongoing initiatives towards business partnerships and non-cash M&A transactions, together with the improved financial position, provide reasonable grounds for the continued preparation of the financial statements on a going concern basis.
Historical Stock Returns for Take Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.28% | -1.74% | -15.65% | -41.93% | +117.60% | -61.32% |
What specific business diversification strategies and partnerships is the company pursuing to replace the revenue lost from the Ecron Acunova divestment?
How does management plan to resolve the ongoing income tax disputes, and what is the potential financial impact if the courts rule against the company?
Will the company utilize its improved financial position and equity to pursue the mentioned non-cash M&A transactions in the near term?






























